THE H. PYLORI SHIFT 

 New Guidelines. New Evidence.

New Treatment Approach. 

Dr. Vivian Abenaa Asamoah, MD, IFMCP

Wednesday, June 03, 2026

6:00 PM CST (4:00 PM PDT / 7:00 PM EDT)

Live in Katy, TX for local attendees.

Virtual login available for all others.

Registration is mandatory. Please register below.

This educational event will highlight the major updates in the 2024 H. pylori treatment guidelines and their implications for real-world clinical practice. With rising antibiotic resistance reshaping first-line therapy, many commonly used regimens, particularly clarithromycin- and metronidazole-based therapies, are no longer recommended as empiric options.

Program is non-promotional and supported through an Educational Grant provided by THI.